All In MedTech

FDA Clearance Tracker · P230023-S006

GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis (TAMBE)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 20, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 20, 2025

Approved

Time to decision

179 days

Received Nov 22, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P230023-S006
Device name
GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis (TAMBE)
Applicant location
Flagstaff, AZ
Received
Nov 22, 2024
Decided
May 20, 2025
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P230023

Device type

Device class
Class III

Every decision under product code QZK

FDA's approval statement

As written in FDA's record.

use of the Reduced Profile GORE VIABAHN VBX Balloon Expandable Endoprosthesis as a branch component option for the GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis (TAMBE)

Source documents

Other decisions for W. L. Gore & Associates, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.